Displaying 1 - 25 of 124
Source:
Person
Aine Yung
Dr. Yung joined NeoGenomics in 2018. Before joining NeoGenomics, Dr. Yung worked at Genoptix where she served as a Senior Hematopathologist. Dr. Yung completed her combined Anatomic Pathology and…
Source:
Person
Ainura Kyshtoobayeva
Ainura Kyshtoobayeva has been with NeoGenomics since December 2016 serving as the Technical Director and Chief Test Development IHC. Previously she worked as the director of IHC…
Source:
Person
Albert Ho
Dr. Ho is board certified in Anatomic Pathology (AP), Clinical Pathology (CP) and Hematopathology. Prior to joining NeoGenomics, he served as Medical Director of Molecular Oncology at Quest…
Source:
Person
Ali Olivo
Ali has been serving as Interim General Counsel since mid-April 2022.
Ms. Olivo has more than 14 years of corporate and legal expertise. She has been with NeoGenomics for nearly three years…
Source:
Person
Alison L. Hannah
Dr. Hannah has served as a director since June 2015. Dr. Hannah has over 25 years' experience in the development of investigational cancer chemotherapies. Since 2000, she has served as a…
Source:
Person
Anahit Nowrouzi
Dr. Nowrouzi started at NeoGenomics on March 1, 2021. She is an AP/CP and Hematopathology Board Certified Pathologist. Before joining NeoGenomics, she worked as a Hematopathologist and the…
Source:
Person
Anna Juncker-Jensen
Anna Juncker-Jensen is a Senior Scientist at NeoGenomics, where she is responsible for scientific and operational aspects of MultiOmyx study execution and data interrogation. She…
Source:
Person
Anselm Hii
Dr. Hii is a practicing pathologist and board certified in Anatomic and Clinical Pathology as well as Hematology. Prior to providing services to NeoGenomics, he served as Senior Pathologist and…
Source:
Person
Anthony Padula
Born and raised a New Yorker, Dr. Padula decided to move to Europe to attend medical school in Italy at the University of Rome where he also did research in Pediatric Oncology. Upon…
Source:
Person
Armen Kaysan
Dr. Kasyan joined NeoGenomics as a Pathologist in 2022. Before joining NeoGenomics, Dr. Kasyan worked as an anatomic and clinical pathologist in Houston, Texas. He completed his Anatomic and Clinical Pathology residency at University of California,…
Source:
Person
Bernard A Fox
Harder Family Chair for Cancer Research
Member and Chief,
Laboratory of Molecular & Tumor Immunology
Earle A. Chiles Research Institute
Robert W. Franz Cancer Center
Providence Cancer…
Source:
Person
Bora Baysal
Dr. Baysal joined NeoGenomics as a Senior Hematopathologist in 2022. Before joining NeoGenomics, Dr. Baysal served as an Associate Professor of Oncology and a Staff Physician (Hematopathology)…
Source:
Person
Brian Kwok
Dr. Kwok joined NeoGenomics in 2018. Before joining NeoGenomics, Dr. Kwok worked at Genoptix for 7 years, where he initially served as Staff Hematopathologist, and later as Senior…
Source:
Person
Brittany J. Bell
Brittany J. Bell has been working at NeoGenomics for 5 years, specifically supporting and leading Pharma Services under the Advanced Diagnostics Division. She brings over 10 years of…
Source:
Person
Bruce K. Crowther
Mr. Crowther has served as a Director since October 2014. Mr. Crowther retired in 2013 as President and Chief Executive Officer of Northwest Community Healthcare where he served for 23…
Source:
Person
Carlo Croce
Distinguished University Professor
The John W. Wolfe Chair in Human Cancer Genetics
The Ohio State University, Columbus, Ohio, USA
His research has revealed the variety of mutated genes…
Source:
Person
Catina Mahr
Source:
Person
Charlotte Serra
With 18 years’ experience in Research, Process Development/Characterization, Production, QC, QA, Regulatory Affairs, Budget Planning, and Business Development in the healthcare industry (…
Source:
Person
Chris Smith
Chris joins NeoGenomics from OrthoClinical Diagnostics where he served as Chairman and CEO from 2019 to May of 2022. During his leadership, OrthoClinical raised $1.45 billion in funding in a Q1…
Source:
Person
Chunghun George Chang
Dr. Chang earned his MD at New York Medical College ad completed Diagnostic Radiology and Pathology & Laboratory Medicine residencies, and Surgical Pathology and Hematopathology…
Source:
Person
David Perez
With 40 years of executive leadership in medical device and health care services, David Perez serves as an independent board member and advisor to several corporations and non-profit…
Source:
Person
Dennis P. O’Malley
Dr. O’Malley currently serves as a Hematopathologist at NeoGenomics and as an Adjunct Associated Professor at MD Anderson Cancer Center, University of Texas. Dr. O’Malley completed two…
Source:
Person
Derek Lyle
Dr. Lyle joined NeoGenomics in 2018. Before joining NeoGenomics, Dr. Lyle worked at Genoptix Medical Laboratory for 9 years, where he initially served as Director of Hematopathology and, later,…
Source:
Person
Edgardo Santos
Dr. Edgardo Santos (FACP) is a Medical Oncologist with Florida Precision Oncology and specializes in thoracic oncology and head and neck cancer. Dr. Santos previously served as the Medical…
Source:
Person
Elizabeth Floegel
Elizabeth Floegel has a track record for successfully leading technology and organizational transformation in highly matrixed environments. As Chief Information & Digital Officer of…